Piper Sandler Raises Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $55.00

Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Rating) had its price target boosted by Piper Sandler from $43.00 to $55.00 in a research report sent to investors on Thursday, The Fly reports. Separately, StockNews.com lowered Amphastar Pharmaceuticals from a strong-buy rating to a buy rating in a research note on Tuesday, June 13th. Amphastar Pharmaceuticals Trading Up […]

Related Keywords

Montreal ,Quebec ,Canada ,Piper Sandler ,Yakob Liawatidewi ,Howard Lee ,Amphastar Pharmaceuticals ,Amphastar Pharmaceuticals Trading ,Envestnet Asset Management Inc ,News Ratings For Amphastar Pharmaceuticals Daily ,Institutional Investors Weigh In On Amphastar Pharmaceuticals ,Amphastar Pharmaceuticals Inc ,Citigroup Inc ,York Mellon Corp ,Nasdaq ,Raymond James Associates ,Amphastar Pharmaceuticals Company Profile ,Get Rating ,Director Howard Lee ,Asset Management ,New York Mellon Corp ,Montreal Can ,Finished Pharmaceutical Products ,Active Pharmaceutical Ingredients Products ,Amphastar Pharmaceuticals Daily ,Nasdaq Amph ,Amph ,Medical ,Boost Price Target ,